<p>SurModics Inc. has announced the anticipated completion of a merger, prompting significant regulatory actions. The company notified the Nasdaq Stock Market of the planned merger and requested a trading halt of its common stock effective November 18, 2025. Following the merger’s consummation on November 19, 2025, SurModics asked Nasdaq to delist its common stock and filed for deregistration with the Securities and Exchange Commission. Additionally, the company intends to terminate its reporting obligations under the Securities Exchange Act of 1934. These steps mark a substantial change in the company’s public reporting and trading status. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SurModics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-288169), on November 19, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

SRDX

<p>SurModics Inc. plans to delist its shares from Nasdaq following a merger completion on November 19, 2025. The company has requested a trading halt effective November 18, 2025, and filed for deregistration with the SEC, marking a significant change in its public reporting and trading status.</p>

Surmodics to Delist Shares Following Merger Completion